Technology
A new, hand-held creatinine monitoring system, Nova StatSensor Creatinine, was released in January by Nova Biomedical ...
February 20, 2008
Technology
Toshiba America Medical Systems Inc.'s dynamic volume computed tomography (CT) system, the Aquilion ONE, is an advanced diagnostic imaging system that can image an entire organ in a single rotation or over multiple rotations, showing real-time dynamic movement.
February 20, 2008Technology
In January the FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the ...
February 20, 2008Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
Technology
Toshiba America Medical Systems Inc. recently introduced its Infinix VF-i/SP X-ray system, a universal cardiovascular ...
February 19, 2008
Technology
The ACUSON X300 works to provide compact, portable color Doppler solutions for adult, pediatric, OR, EP and ...
February 19, 2008News
February 20, 2008 - At HIMSS 2008, Siemens Healthcare will emphasize its image data management solutions for radiology ...
February 19, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026
Feature | Dave Fornell
February 2008 - The traditional hospital cleaning methods of wiping down surfaces and mopping floors are now being ...
February 19, 2008
Technology
Siemens Medical Solutions received FDA 510(k) clearance for a 1.5T magnetic resonance imaging (MRI) system that is ...
February 19, 2008
Technology
W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.
February 19, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
February 20, 2008 - Philips Medical Systems features at HIMSS 2008 enhancements to its speech recognition solution ...
February 19, 2008News
February 19, 2008 - Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery, according to a report in the January 15 issue of the American Journal of Cardiology.
February 18, 2008News
February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted in Europe, as Terumo Corp. is poised to expand the product from spring 2008 to more than 20 countries in Europe, Asia, New Zealand and Africa.
February 18, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with stent placement, reports a study in the February 26, 2008 issue of the Journal of the American College of Car
February 18, 2008News
February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.
February 18, 2008News
February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15. The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.
February 18, 2008